(Q48161996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

0 references

anaplastic oligodendroglioma

1 reference

based on heuristic

inferred from title

adult oligodendroglioma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

François Ducray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Monica Sierra del Rio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Catherine Carpentier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Dimitri Psimaras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Caroline Dehais

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gentian Kaloshi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Karima Mokhtari

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sophie Taillibert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Florence Laigle-Donadey

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Antonio Omuro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marc Sanson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jean-Yves Delattre

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Khê Hoang-Xuan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

17 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

457-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20556480%20AND%20SRC:MED&resulttype=core&format=json

The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Descriptive epidemiology of cerebral gliomas in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

The treatment of elderly patients with high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Primary brain tumours in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Diagnostic and prognostic markers in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Survey of treatment recommendations for anaplastic oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Prognostic stratification of patients with anaplastic gliomas according to genetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Age influences chemotherapy response in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0264-Z